Central nervous system prophylaxis with high-dose intravenous methotrexate or intrathecal chemotherapy in patients with diffuse large B-cell lymphoma and high-risk of CNS relapse treated in the rituximab era Meeting Abstract

  

Authors:	Bobillo, S.; Joffe, E.; Seshan, V.; Noy, A.; Horwitz, S. M.; Palomba, M. L.; Matasar, M. J.; Straus, D. J.; Hamlin, P. A.; Batlevi, C. L.; Ghione, P.; Sermer, D.; Moskowitz, A. J.; Hamilton, A.; Caron, P.; Owens, C.; von Keudell, G. R.; Dogan, A.; Zelenetz, A. D.; Younes, A.
Abstract Title:	Central nervous system prophylaxis with high-dose intravenous methotrexate or intrathecal chemotherapy in patients with diffuse large B-cell lymphoma and high-risk of CNS relapse treated in the rituximab era
Meeting Title:	61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	134
Issue:	Suppl. 1
Meeting Dates:	2019 Dec 7-10
Meeting Location:	Orlando, FL
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2019-11-13
Language:	English
ACCESSION:	WOS:000577160402171
DOI:	10.1182/blood-2019-131435
PROVIDER:	wos
Notes:	Meeting Abstract: 1619 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/175621